Le Lézard
Subject: MAT

Hollister Biosciences Announces Listing on Frankfurt Stock Exchange


VANCOUVER, Dec. 10, 2019 /CNW/ - Hollister Biosciences Inc. ("Hollister" or the "Company") (CSE: HOLL) is pleased to announce that it is now listed on the Frankfurt Stock Exchange and is trading under the symbol HOB.

Hollister Biosciences Inc. (CNW Group/Hollister Biosciences Inc.)

The Frankfurt Stock Exchange is one of the world's largest trading centers for securities, and it is the largest stock exchange in Germany. The Frankfurt Stock Exchange is used by over 250 trading institutions and ranks third globally in trade volume, following only the New York Stock Exchange and NASDAQ.

About Hollister Biosciences Inc.

Hollister Biosciences Inc. is a California based vertically integrated cannabis company with a vision to be the sought-after premium brand portfolio of innovative, high-quality California-grown cannabis & hemp products. Hollister uses a vertically integrated, high margin model, controlling the whole process from manufacture to sales to distribution or seed to shelf. Products from Hollister Cannabis Co. include HashBone, the brand's premier artisanal hash-infused pre-roll, along with solvent-free bubble hash, pre-packaged flower, pre-rolls, tinctures, vape products, and full-spectrum high CBD pet tinctures. Hollister Cannabis Co. additionally offers white-labeling manufacturing of cannabis products.

Our wholly owned California subsidiary Hollister Cannabis Co is the 1st state and locally licensed cannabis company in the city of Hollister, CA birthplace of the "American Biker".

ON BEHALF OF THE BOARD of DIRECTORS

Hollister Biosciences Inc.

"Carl Saling"
CEO and Director

Company Contact
klee@k2capital.ca
Tel: 604-961-0296

Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Information: This news release includes certain statements that may be deemed "forward-looking statements". The use of any of the words "anticipate", "continue", "estimate", "expect", "may", "will", "would", "project", "should", "believe" and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this News Release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company's disclosure documents which can be found under the Company's profile on www.sedar.com

SOURCE Hollister Biosciences Inc.



News published on 10 december 2019 at 09:30 and distributed by: